Dana Kralicek

My research aim is to design point-of-care tools to non-invasively detect proteins, small molecules, and DNA mutations in complex matrices like saliva, blood and urine. I utilize giant-magnetoresistive sensors coupled with super paramagnetic nanoparticles to develop quantitative assays that can be multiplexed with virtually any biomarker (proteins, peptides, drugs, etc.). This robust platform allows me to answer fundamental questions involving drugs, like morphine and THC, as well as steroid hormones, like cortisol. My current projects include working with anesthesiologists at Stanford Medical School to develop opioid monitoring tools for intraoperative care and working with psychologists at Stanford's Center for Stress developing DNA mutation detection tools for characterization of hypnotic susceptibility.